Myeloid lineage-associated markers: Difference between revisions
From haematologyetc.co.uk
No edit summary |
No edit summary |
||
| Line 10: | Line 10: | ||
<div style="width: 95%"> | <div style="width: 95%"> | ||
{| class="wikitable" style="border-style: solid; border-width: 5px; color:black" | {| class="wikitable" style="border-style: solid; border-width: 5px; color:black" | ||
|colspan="2" style = "font-size:90%; color:black; background:lightgrey" |Assignment of myeloid lineage: Lineage-associated markers | |colspan="2" style = "font-size:90%; color:black; background:lightgrey" |'''Assignment of myeloid lineage: Lineage-associated markers''' | ||
|- | |- | ||
|colspan="2" style = "font-size:90%; color:black; background:#ddeee1"|'''Pattern 2''':</br> | |colspan="2" style = "font-size:90%; color:black; background:#ddeee1"|'''Pattern 2''':</br>Myeloid lineage assignment using these markers requires that at least '''two myeloid lineage-associated''' markers are present | ||
|- | |- | ||
|colspan="1" style = "font-size:90%; color:black;" |'''[[CD117]]''' | |colspan="1" style = "font-size:90%; color:black;" |'''[[CD117]]''' | ||
Revision as of 19:50, 5 January 2024
| Assignment of myeloid lineage: Lineage-associated markers | |
| Pattern 2: Myeloid lineage assignment using these markers requires that at least two myeloid lineage-associated markers are present | |
| CD117 | An early marker of myeloid lineage, seen in up to 80% of AML and vauable in recognising more primitive differentaiion forms (note that aberrant expression is seen in up to 20% of ALL cases) |
| CD33 | A good marker for AML, particularly for those cases with granulocytic maturation, CD33 is often less strongly expressed in AML with monocytic dfferentiation and strongly expressed in APL. |
| CD13 | A good lineage marker for AML that is acquired a little later in differentation than CD117 or CD33; expression of CD13 is often higher than CD33 in AML with monocytic differentiation. |